Chlamydia pneumoniae IgM Test | Lahalak Platform

Targeted test to detect active or early Chlamydia pneumoniae infection, enabling immediate therapeutic intervention to maintain lung integrity and respiratory efficiency.

Prices starts from: 84.47 SAR

Scientific name: Chlamydia pneumoniae IgM Antibody Test

Chlamydia pneumoniae IgM antibodies in serum (Chlamydia pneumoniae Abs IgM, Serum) is a targeted test used to detect the presence of IgM antibodies against Chlamydia pneumoniae in the blood. This type of antibody typically appears during the acute or early stages of infection. The test helps diagnose active respiratory infections caused by this bac...

Chlamydia pneumoniae IgM Antibody Test - Chlamydia pneumoniae IgM Test
Service type Laboratory test (Blood)
Duration 10-15 minutes
Fasting Fasting is not required
Prices Starting from 84.47 SAR

Included Services

  • Chlamydia pneumoniae Abs IgM, Serum Test
  • The optimal health guidance based on the result.
  • Personal support services from Lahalak

Medical Service Information

Purpose Test

  • Active or acute infection: IgM antibodies are the first type produced by the body during a new or active infection. High levels of IgM indicate an acute Chlamydia pneumoniae infection, which helps in the early diagnosis of respiratory infections.
  • Early diagnosis of pneumonia: The test helps detect acute pneumonia or bronchitis caused by Chlamydia pneumoniae, especially in the early stages of infection before the body produces IgG antibodies.
  • Distinguishing recent from past infection: The test helps differentiate between recent and past infections, as IgM antibodies appear early and disappear over time, whereas IgG antibodies persist for a longer duration.

Recommended groups

  • Patients with severe respiratory symptoms: Such as severe cough, fever, shortness of breath, and chest pain, especially if symptoms suggest possible pneumonia or bronchitis caused by Chlamydia pneumoniae.
  • Recently diagnosed with a respiratory infection: If there are acute respiratory symptoms accompanied by fever or rapid deterioration of health, the test can help diagnose active infection and determine if it is caused by Chlamydia pneumoniae.
  • Patients with unexplained pneumonia: Individuals with unexplained pneumonia or bronchitis, particularly if the infection does not respond to conventional treatment.
  • Immunocompromised individuals or those with chronic diseases: Such as patients with asthma, chronic obstructive pulmonary disease (COPD), or weakened immune systems (e.g., patients receiving immunosuppressive therapy), who may be more susceptible to active Chlamydia pneumoniae respiratory infection.
  • Individuals exposed to high-risk environments: Such as healthcare workers or those in hospital settings where exposure to bacteria causing respiratory infections is higher.
  • Patients with recurrent or chronic respiratory symptoms: Such as chronic cough or repeated unexplained pneumonia, which may require investigation for persistent or chronic Chlamydia pneumoniae infection.

Symptoms indicative

  • Severe cough: Persistent or severe cough that does not respond to standard treatment, especially if accompanied by other respiratory symptoms such as shortness of breath or chest pain.
  • Fever: Persistent or intermittent elevated temperature accompanied by fatigue, which is common in acute respiratory infections such as pneumonia.
  • Shortness of breath: Difficulty breathing or wheezing, which may indicate pneumonia or bronchitis caused by Chlamydia pneumoniae.
  • Chest pain: Feeling of pain or pressure in the chest, a common symptom in acute respiratory infections.
  • Fatigue and general tiredness: Severe fatigue or unexplained tiredness, which may result from an acute respiratory infection caused by Chlamydia pneumoniae.
  • Acute pneumonia: Symptoms indicating acute pneumonia, such as productive cough with phlegm, fever, and difficulty breathing, may indicate the need for this test to determine if the infection is caused by Chlamydia pneumoniae.

FAQs

  • What is the Chlamydia pneumoniae IgM Antibodies Test? It is a test used to detect IgM antibodies produced by the body during an active or acute infection with Chlamydia pneumoniae, a bacterium that causes respiratory infections such as pneumonia and bronchitis.
  • When should this test be done? It is recommended if you have severe respiratory symptoms such as a strong cough, fever, shortness of breath, or chest pain, which may indicate an active respiratory infection caused by Chlamydia pneumoniae.
  • Does this test detect active infection? Yes, IgM antibodies are the body’s first immune response during a new or active infection, making them an indicator of acute Chlamydia pneumoniae infection.
  • Does the test diagnose recurrent or chronic infection? No, IgM antibodies appear only in active or acute stages. For detecting past or chronic infections, IgG antibody testing is used.
  • How is the test performed? A blood sample is drawn from a vein using a medical needle, then sent to the laboratory to measure IgM antibody levels against Chlamydia pneumoniae in the serum.
  • Is the test painful? The test is not significantly painful; the blood draw may cause slight discomfort.

Normal Levels

  • Negative Result: If IgM antibody levels against Chlamydia pneumoniae are low or undetectable, it means that the person either has not been exposed to the bacteria or that there is no active infection currently. A negative result usually indicates no active infection.
  • Positive Result: If IgM antibody levels are elevated, it indicates that the person has recently been exposed to an active Chlamydia pneumoniae infection. High levels suggest that the infection may be recent or currently active.
  • Reference values may vary between laboratories due to differences in equipment and testing methods.
  • It is always important to refer to the reference ranges provided by the laboratory that performed the test.
  • Interpretation by a physician may be required based on clinical symptoms and other test results, as a positive result may indicate an acute or recent infection.
  • Negative result: No IgM antibodies → No active infection.

Conditions & Notices

  • The terms and conditions announced on the "Lahalak" medical platform apply.
  • There are no special conditions for the service other than those mentioned.

Medical services you might also like